NCT03374735 is a NA clinical trial of SETALUM™ Sealant in Vascular Diseases, sponsored by Gecko Biomedical.

Who is sponsoring NCT03374735?

NCT03374735 is sponsored by Gecko Biomedical.

What drugs are being tested in NCT03374735?

Interventions in NCT03374735: SETALUM™ Sealant.

What condition does NCT03374735 study?

NCT03374735 studies Vascular Diseases.

Is NCT03374735 still recruiting?

NCT03374735 is currently completed. Last updated 15 December 2017.

Last reviewed 2017-12-15 · How we verify

NCT03374735

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

First In-human Use of SETALUM™ Sealant: The BlueSeal Clinical Study

Completed NA Last updated 15 December 2017

What this trial tests

NA trial testing SETALUM™ Sealant in Vascular Diseases in 22 participants. Completed in 3 October 2017.

Timeline

15 March 2016

Primary endpoint
7 February 2017

3 October 2017

Quick facts

Lead sponsor	Gecko Biomedical
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	22
Start date	15 March 2016
Primary completion	7 February 2017
Estimated completion	3 October 2017

Drugs / interventions tested

SETALUM™ Sealant

Conditions studied

Vascular Diseases — all drugs for Vascular Diseases →

Sponsor

Gecko Biomedical

Who can join

18 and older, any sex, with Vascular Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a prospective, multicenter, single-arm trial to evaluate the safety and performance of SETALUM™ Sealant in sealing suture lines at the anastomosis between native vessels and synthetic ePTFE vascular patch used during open vascular surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Vascular Diseases

Currently open trials in the same condition.

NCT06615973 — Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke · recruiting
NCT07427108 — Road Mapping Guided Puncture Versus Ultrasound Guided Puncture During Retrograde Angioplasty Feasibility and Safety · NA · recruiting
NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
NCT07185022 — Intra-arterial Thrombolysis for Acute Ischemic Stroke With Medium Vessel Occlusion · NA · recruiting
NCT07286578 — A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Under · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03374735 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Gecko Biomedical
Last refreshed: 15 December 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03374735.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing